Covestro and ParaMatters develop anisotropic optimization software for composites
17 Sep 2021
Photo Credit: Covestro
Materials company Covestro (Leverkusen, Germany) and ParaMatters (Ventura, Calif., U.S.), a multi-threaded generative design and manufacturing optimization software company, announced a jointly developed optimization software for anisotropic materials.
By combining ParaMatters’ expertise in design and manufacturing optimization technology and Covestro’s knowledge in engineered materials, the two companies are delivering a complete anisotropic design and workflow of filament extrusion 3D printing with fiber-reinforced materials.
According to the companies, by using the new optimization tool, designers and engineers can quickly obtain the most optimal part design based on material deposition and fiber orientation, and generate the most efficient printer toolpath. The result is materials, weight and cost savings — while maintaining part performance.
Following successful initial evaluation by leading aerospace users, including Composite Technology Center GmbH (Stade, Germany), on multiple filament extrusion printers, Covestro and ParaMatters are introducing the beta version so more users can try anisotropic materials. Users who want to join the expanding beta program, as well as providers of filament-based extrusion 3D printers that want to qualify and certify their systems, can contact ParaMatters to request more information.
Avi Reichental, ParaMatters’ co-founder and chairman, says, “We are proud to partner with Covestro and be the first to market with such a powerful design and manufacturing optimizer.”
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.